Endocrinology 152 , 48254837 (2011)
Beyond assessing symptoms and signs, HF diagnosis heavily depends on LVEF as a measure of ventricular cavity function, typically evaluated through 2D echocardiography in clinical settings
Additional experimental and large-scale clinical designs with optimal dose and duration of homocysteine-lowering treatment are needed to definitively prove that homocysteine is responsible for the increased risk of cardiovascular disease, mostly of atherosclerosis
Research shows that GHK-Cu in face and eye creams may reduce lines, wrinkles, and age spots (hyperpigmentation), and improve skin moisture, elasticity, and thickness
Implementation of these approaches requires commitment from healthcare providers, systems, and policymakers but does not depend on future research breakthroughs
Berberine and health outcomes: an umbrella review